Should Pharma and Congress do more to cut drug prices?

In a conference call with reporters, Health and Human Services (HHS) Secretary Alex Azar said Congress and drugmakers should be doing more to lower the cost of prescription drugs. Azar gave the example of “The industry could move further to a fixed price discount system at the point of sale;” there’s nothing stopping them. To read more of Secretary Azar’s comments, click on attached link. Click here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.